The Chemours Company CC
12.93 USD -0.35 (-2.65%)
Nov 10, 2026, 11:07 AM EST
12.79 Day range 13.17
10.44 52-week range 28.67
- YTD
- +9.65%
- 1 year
- +1.39%
News
prnewswire.com CC Investor Notification: Chemours Sued for Securities Fraud on behalf of Investors with Losses after Opteon Demand Issues Lead to 18% Stock Drop Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products. NEW YORK, Nov. 10, 2026…
benzinga.com JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $14 JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $14.
globenewswire.com CC Stock Alert: Chemours Stock Plummets 18% after Opteon Demand Issues Disclosed – Contact BFA Law about the Pending Securities Fraud Class Action NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and…
prnewswire.com CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law LOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company…
newsfilecorp.com CC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or…
prnewswire.com The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC NEW YORK and NEW ORLEANS, Nov. 6, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial…
newsfilecorp.com Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against The Chemours Company (CC) on December 7, 2026 New York, New York--(Newsfile Corp. - November 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company")…
globenewswire.com CC Court Deadline Reminder: Chemours Investors Have until December 7 until Expiration of Securities Fraud Class Action Deadline – Contact BFA Law NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and…
prnewswire.com Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers - CC NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers.…
zacks.com CC Launches Faizeon Cooling Solutions to Meet AI Data Center Demand Chemours launches Faizeon two-phase liquid cooling solutions to tackle AI data center heat challenges, offering improved efficiency and reduced water consumption.
newsfilecorp.com CC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or…
defenseworld.net What Chemours (CC) Said on Its Q3 Earnings Call Chemours (NYSE: CC) said third-quarter 2026 net sales increased 3% from a year earlier, as pricing momentum in Titanium Technologies and growth in Advanced Performance Materials offset weaker demand…
benzinga.com UBS Maintains Neutral on Chemours, Lowers Price Target to $15 UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $16 to $15.
prnewswire.com What's Next for The Chemours Company Shareholders After 18.63% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline Complaint alleges The Chemours Company misled investors between February 20, 2026 and August 4, 2026; investors may seek lead plaintiff role by December 7, 2026 LOS ANGELES, Nov. 4, 2026 /PRNewswire/…
247wallst.com The SEC Just Called Canton Coin a Digital Commodity, Not a Security. What Did Canton Have to Prove to Get That Letter? The SEC handed Canton Coin a rare digital commodity classification, but passing that legal test required meeting two specific conditions that most crypto projects quietly fail. Whether the ruling…- benzinga.com Truist Securities Maintains Buy on Chemours, Lowers Price Target to $18 Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $20 to $18.
prnewswire.com Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 7, 2026 - CC Alert: Claims Focus on Alleged Misrepresentations About TSS Channel Inventory. The lawsuit centers on roughly $65 million in Opteon refrigerant aftermarket sales that distributor stocking allegedly…
newsfilecorp.com CC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or…
newsfilecorp.com Kaplan Fox Reminds Investors of a Securities Class Action Against The Chemours Company (CC) - Deadline is December 7, 2026 New York, New York--(Newsfile Corp. - November 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company")…
globenewswire.com CC Class Reminder: Chemours Opteon Demand Issues Trigger Securities Fraud Class Action for Investors – Contact BFA Law if You Lost Money NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and…
defenseworld.net Financial Survey: Chemours (NYSE:CC) vs. Quaker Houghton (NYSE:KWR) Chemours (NYSE: CC - Get Free Report) and Quaker Houghton (NYSE: KWR - Get Free Report) are both materials companies, but which is the superior stock? We will contrast the two companies based on the…
globenewswire.com The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC NEW YORK and NEW ORLEANS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with…
globenewswire.com Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers – CC NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain…
seekingalpha.com The Chemours Company (CC) Q3 2026 Earnings Call Transcript The Chemours Company ( CC ) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director…
prnewswire.com What Does The Chemours Company's 18.63% Stock Drop Mean for Investors? The Law Offices of Howard G. Suit alleges The Chemours Company failed to disclose key facts to investors from February 20, 2026 through August 4, 2026; lead plaintiff deadline is December 7, 2026 BENSALEM TOWNSHIP, Pa., Nov. 3,…
feeds.newsfilecorp.com Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - November 3, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
globenewswire.com Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours…
globenewswire.com CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law LOS ANGELES, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours…
marketbeat.com What Chemours (CC) Said on Its Q3 Earnings Call Chemours NYSE: CC said third-quarter 2026 net sales increased 3% from a year earlier, as pricing momentum in Titanium Technologies and growth in Advanced Performance Materials offset weaker demand in…
globenewswire.com CC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in The Chemours Company Securities Lawsuit - Contact SueWallSt NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SueWallSt notifies pension funds, asset managers, and other institutional investors in The Chemours Company (NYSE: CC) that a class action lawsuit has been…
benzinga.com Chemours Q3 2026 Earnings Call Transcript Chemours (NYSE:CC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
prnewswire.com Robbins LLP Urges CC Shareholders to Contact the Firm for Information About The Chemours Company Securities Class Action SAN DIEGO, Nov. 3, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired…
prnewswire.com CC Shareholder Notice: Chemours Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 7 Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products. NEW YORK, Nov. 3, 2026…
benzinga.com Chemours Narrows FY2026 Sales Guidance from $5.866B-$6.098B to $5.924B vs $5.917B Est Chemours (NYSE:CC) narrows FY2026 sales outlook from $5.866 billion-$6.098 billion to $5.924 billion vs $5.917 billion estimate.
benzinga.com Chemours Q3 Adj. EPS $0.21 Misses $0.27 Estimate, Sales $1.540B Inline Chemours (NYSE:CC) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.27 by 22.22 percent. This is a 5 percent increase over earnings of $0.20 per share…- benzinga.com Truist Securities Maintains Buy on Chemours, Lowers Price Target to $20 Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $24 to $20.
benzinga.com This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.
benzinga.com Mizuho Downgrades Chemours to Neutral, Lowers Price Target to $15 Mizuho analyst John Roberts downgrades Chemours (NYSE:CC) from Outperform to Neutral and lowers the price target from $18 to $15.
benzinga.com Barclays Initiates Coverage On Chemours with Equal-Weight Rating, Announces Price Target of $16 Barclays analyst Aleksey Yefremov initiates coverage on Chemours (NYSE:CC) with a Equal-Weight rating and announces Price Target of $16.
benzinga.com Chemours Q2 2026 Earnings Call: Complete Transcript Chemours (NYSE:CC) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time…- benzinga.com UBS Maintains Neutral on Chemours, Lowers Price Target to $16 UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $18 to $16.
- benzinga.com Mizuho Maintains Outperform on Chemours, Lowers Price Target to $18 Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $20 to $18.
benzinga.com Why Is Chemours Stock Trading Higher Today? Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing and future escrow obligations.- benzinga.com Chemours, DuPont De Nemours And Corteva Reach Settlement State Of North Carolina And 11 Local Entities; Overall Settlement Payments Total $455M Over 15 Years, With Chemours' 50% Share Of Payments Of ~$180M On NPV Basis Covered By Existing Accruals The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the
- benzinga.com JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $15 JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $22 to $15.
benzinga.com BMO Capital Maintains Outperform on Chemours, Lowers Price Target to $18 BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $26 to $18.
benzinga.com Dick's Sporting To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday Analysts update ratings on top stocks. View all changes, including upgrades and downgrades, on analyst ratings page.- benzinga.com UBS Downgrades Chemours to Neutral, Lowers Price Target to $18 UBS analyst Joshua Spector downgrades Chemours (NYSE:CC) from Buy to Neutral and lowers the price target from $29 to $18.
- benzinga.com Chemours Launches Of Opteon ZE And Opteon 515B For Stationary Chiller Applications Required By Data Centers The products further expand the industry-leading Opteon™ portfolio and provide customers with additional low-global warming potential (GWP) refrigerant options for large-scale cooling applications,…
benzinga.com RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $22 RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $26 to $22.